BioWorld MedTech briefs for January 30, 2024.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: AB Science, Ascidian, Astellas, Astrazeneca, Celltrion, Daewoong, Daiichi, Gracell, GSK, Halozyme, Oricell, Takeda, Tonix.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Agilent, Alpha-9, Arcus, Avrobio, Bridgebio Can-Fite, Cidara, Concentra, Cormedix, Ewopharma, Fabentech, Gilead, Incyte, Invitae, Ionis, ITM, J&J, Maxcyte, Mundipharma, Nanobio, Qubit, Tetonic, Theseus, Vaxxinity, Vect-Horus, Wugen.